KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Asset Writedowns and Impairment (2016 - 2025)

TherapeuticsMD filings provide 14 years of Asset Writedowns and Impairment readings, the most recent being $1.3 million for Q1 2025.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $1.3 million in Q1 2025 year-over-year; TTM through Mar 2025 was $1.3 million, a N/A change, with the full-year FY2024 number at $1.3 million, changed N/A from a year prior.
  • Asset Writedowns and Impairment hit $1.3 million in Q1 2025 for TherapeuticsMD, up from $7000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.3 million in Q1 2025 to a low of -$540000.0 in Q4 2021.
  • Median Asset Writedowns and Impairment over the past 5 years was $215000.0 (2021), compared with a mean of $207666.7.
  • The widest YoY moves for Asset Writedowns and Impairment: up 462.08% in 2021, down 208.0% in 2021.
  • TherapeuticsMD's Asset Writedowns and Impairment stood at -$540000.0 in 2021, then skyrocketed by 149.63% to $268000.0 in 2022, then tumbled by 77.99% to $59000.0 in 2023, then tumbled by 88.14% to $7000.0 in 2024, then soared by 17914.29% to $1.3 million in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $1.3 million (Q1 2025), $7000.0 (Q4 2024), and $59000.0 (Q1 2023) per Business Quant data.